8,358,000 Shares And Warrants to Purchase 2,925,300 Shares ANADYS PHARMACEUTICALS, INC. Common Stock PLACEMENT AGENT AGREEMENTPlacement Agent Agreement • June 4th, 2009 • Anadys Pharmaceuticals Inc • Pharmaceutical preparations • New York
ANADYS PHARMACEUTICALS, INC. Warrant To Purchase Common StockWarrant to Purchase Common Stock • June 4th, 2009 • Anadys Pharmaceuticals Inc • Pharmaceutical preparations • New York
Anadys Pharmaceuticals, Inc., a Delaware corporation (the “Company”), certifies that, for good and valuable consideration, the receipt and sufficiency of which are acknowledged, , the registered holder hereof or its permitted assigns (the “Holder”), is entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect, upon surrender of this Warrant to Purchase Common Stock (including any Warrants to Purchase Common Stock issued in exchange, transfer or replacement hereof, the “Warrant”), at any time or times on or after 180 days from the date hereof (the “Exercisability Date”), but not after 5:30 p.m., New York Time, on the Expiration Date (as defined below), ( ) fully paid and nonassessable shares of Common Stock (as defined below) (the “Warrant Shares”). Except as otherwise defined herein, capitalized terms in this Warrant shall have the meanings set forth in Section 15. This Warrant is one of a series of warrants to
Subscription AgreementSubscription Agreement • June 4th, 2009 • Anadys Pharmaceuticals Inc • Pharmaceutical preparations • New York
The undersigned (the “Investor”) hereby confirms and agrees with Anadys Pharmaceuticals, Inc., a Delaware corporation (the “Company”), as follows:
